Tag Archives: API

Mexico at the vanguard with new combination drug

Posted on November 29, 2013 by Maria I. Guaia

In the past days, COFEPRIS granted approval for the combination drug containing fluticasone furoate and vilanterol, indicated for treatment of chronic obstructive pulmonary disease (COPD) and asthma. Although the product had already been approved in the US by the FDA in … Continue reading →

Posted in Mexico | Tagged , , , , , , , , , , , , , , | 1 Comment

Argentina: Site Master File now required by ANMAT for national sites

Posted on November 27, 2013 by Maria I. Guaia

Starting on November 19th, 2o13, sites in Argentina approved by ANMAT to manufacture or package, in own or contract facility, or import or export, both drug products and APIs, have to submit their Site Master Files (SMF) annually. This is … Continue reading →

Posted in Argentina, Uncategorized | Tagged , , , , , , , , , , , , , , | 2 Comments

Brazil: Overview of API registration

Posted on October 28, 2013 by Maria I. Guaia

In Brazil, the health authority (ANVISA) will require that all Active Pharmaceutical Ingredients (APIs) manufactured in Brazil, imported for manufacturing of drug products, or included in imported finished products, are registered with the agency. This regulation has been put in … Continue reading →

Posted in Brazil | Tagged , , , , , , , | 8 Comments

Argentina: checklist for GMP inspections of API facilities

Posted on October 22, 2013 by Maria I. Guaia

On the 3rd of September 2013, ANMAT (regulatory agency in Argentina) issued a new Disposition establishing the guidelines and checklists that will be used by its inspectors for GMP inspections of sites of manufacturing, elaboration, fractionating, distribution, commercialization, exports and imports … Continue reading →

Posted in Argentina, Uncategorized | Tagged , , , , , , | Leave a comment